Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher's Oncomine Lung Cell-Free DNA Assay

Thermo Fisher Scientific has launched its Oncomine Lung Cell-Free DNA (cfDNA) assay. The assay is designed to target mutations in non-small cell lung cancer samples derived from circulating cfDNA in blood. It contains gene targets, such as EGFR and KRAS, and enables analysis with as little as one nanogram of initial sample or samples collected over time from the same subject. The Oncomine Lung cfDNA assay shows 90 percent sensitivity and more than 98 percent specificity at 0.1 percent limit of detection, the company said.